Table 1 GEO studies used to validate DeSigN prediction
From: DeSigN: connecting gene expression with therapeutics for drug repurposing and development
GEO reference | Drug | Response | Number of sensitive samples | Number of resistant samples | Platform | Reference |
|---|---|---|---|---|---|---|
GSE4342 | Gefitinib | Sensitive | 17 | 12 | GPL96 | Coldren et al. [24] |
GSE16179 | Lapatinib | Sensitive | 3 | 3 | GPL570 | Liu et al. [35] |
GSE9633 | Dasatinib | Sensitive | 11 | 5 | GPL571 | Wang et al. [36] |
GSE35141 | Gemcitabine | Resistant | 6 | 6 | GPL4133 | Saiki et al. [37] |